Luise Tittl

Dresden, SN, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications

Venous Thromboembolism Therapy with Edoxaban in Daily Care Patients: Results from the DRESDEN NOAC REGISTRY.

Venous Thromboembolism Therapy with Edoxaban in Daily Care Patients: Results from the DRESDEN NOAC REGISTRY.

Journal: TH open : companion journal to thrombosis and haemostasis
Published: March 10, 2025

Patterns of atrial fibrillation anticoagulation with rivaroxaban - 7-year follow-up from the Dresden NOAC registry.

Patterns of atrial fibrillation anticoagulation with rivaroxaban - 7-year follow-up from the Dresden NOAC registry.

Journal: Thrombosis research
Published: December 29, 2023

Periinterventional Management of Edoxaban in Major Procedures: Results from the DRESDEN NOAC REGISTRY.

Periinterventional Management of Edoxaban in Major Procedures: Results from the DRESDEN NOAC REGISTRY.

Journal: TH open : companion journal to thrombosis and haemostasis
Published: March 29, 2023

Clinical effectiveness and safety of edoxaban in obese patients - Results of the prospective Dresden NOAC Registry (NCT01588119).

Clinical effectiveness and safety of edoxaban in obese patients - Results of the prospective Dresden NOAC Registry (NCT01588119).

Journal: Thrombosis research
Published: January 23, 2023

Pooled Analysis of Rivaroxaban therapy for acute venous thromboembolism in FIRST registry, SWIVTER and DRESDEN NOAC registry.

Pooled Analysis of Rivaroxaban therapy for acute venous thromboembolism in FIRST registry, SWIVTER and DRESDEN NOAC registry.

Journal: Research and practice in thrombosis and haemostasis
Published: June 28, 2022

Effectiveness and safety of edoxaban therapy in daily-care patients with atrial fibrillation. Results from the DRESDEN NOAC REGISTRY.

Effectiveness and safety of edoxaban therapy in daily-care patients with atrial fibrillation. Results from the DRESDEN NOAC REGISTRY.

Journal: Thrombosis research
Published: March 15, 2022

Long-term VTE treatment with rivaroxaban: Results from the DRESDEN NOAC REGISTRY.

Long-term VTE treatment with rivaroxaban: Results from the DRESDEN NOAC REGISTRY.

Journal: Thrombosis research
Published: July 01, 2021

5-year outcomes from rivaroxaban therapy in atrial fibrillation: Results from the Dresden NOAC Registry.

5-year outcomes from rivaroxaban therapy in atrial fibrillation: Results from the Dresden NOAC Registry.

Journal: Thrombosis research
Published: November 11, 2020

Safety of direct oral anticoagulant exposure during pregnancy: a retrospective cohort study.

Safety of direct oral anticoagulant exposure during pregnancy: a retrospective cohort study.

Journal: The Lancet. Haematology
Published: May 04, 2020

Venous Thromboembolism Therapy with Apixaban in Daily Care Patients: Results from the Dresden NOAC Registry.

Venous Thromboembolism Therapy with Apixaban in Daily Care Patients: Results from the Dresden NOAC Registry.

Journal: TH open : companion journal to thrombosis and haemostasis
Published: April 23, 2020

Rates, management and outcome of bleeding complications during edoxaban therapy in daily care - results from the DRESDEN NOAC REGISTRY.

Rates, management and outcome of bleeding complications during edoxaban therapy in daily care - results from the DRESDEN NOAC REGISTRY.

Journal: Thrombosis research
Published: February 03, 2020

Anticoagulation with direct factor Xa inhibitors in transplant recipients: Results from the DRESDEN NOAC REGISTRY (NCT01588119).

Anticoagulation with direct factor Xa inhibitors in transplant recipients: Results from the DRESDEN NOAC REGISTRY (NCT01588119).

Journal: Thrombosis research
Published: December 13, 2019
Showing 1-12 of 29

Last Updated: 09/26/2026